Thirty-day mortality in hospitalised patients with lung cancer: incidence and predictors.
Alessandro LeonettiMarianna PeroniVirginia AgnettiFabiana PratticòMartina ManiniAlessandro AcunzoFrancesca MarvertiSimone SulasElena RapacchiGiulia MazzaschiFabiana PerronePaola BordiSebastiano ButiMarcello TiseoPublished in: BMJ supportive & palliative care (2023)
Our results suggest that baseline poor ECOG PS, high BRASS, presence of pain, high tumour burden and presence of bone metastases could be used as clinical predictors of 30-day mortality in hospitalised patients with lung cancer. In particular, the BRASS scale should be used as a simple tool to predict 30-day mortality in hospitalised patients with lung cancer.